Can Laser Make Melasma Worse? A Myth Check

The question of whether will laser make melasma worse is not paranoia. It is a clinically documented risk that depends heavily on device selection, operator skill, and what happens to the skin in the weeks following treatment. Understanding why requires a look at the biology of melasma itself.

Melasma is a chronic pigmentation disorder driven by overactive melanocytes, the pigment-producing cells in the basal layer of the epidermis. These cells are hyperresponsive to ultraviolet light, heat, and hormonal signals. That last point matters: heat generated during a laser procedure can independently stimulate melanocyte activity. When a laser deposits too much thermal energy into skin that is already primed to overproduce pigment, the result can be a post-inflammatory hyperpigmentation (PIH) response that looks worse than the original melasma.

This is not a theoretical concern. Aggressive ablative resurfacing and high-fluence Q-switched Nd:YAG treatments have been associated with rebound pigmentation in published case series, particularly in patients with Fitzpatrick skin types IV through VI. Darker skin tones carry a higher baseline risk because melanocytes are already more reactive, and any inflammatory signal, including laser-induced heat, can push them into overdrive.

So which lasers are actually used for melasma, and how do they differ in risk? The most studied options include low-fluence Q-switched Nd:YAG (sometimes called the laser toning protocol), picosecond lasers using 532 nm or 1064 nm wavelengths, and fractional nonablative devices like the 1927 nm thulium laser. Low-fluence Nd:YAG works by delivering repeated passes at sub-injury energy levels, targeting melanosomes without triggering significant inflammation. Picosecond devices use ultrashort pulse durations measured in trillionths of a second to shatter pigment mechanically rather than thermally, which in theory reduces heat-related risk. Fractional nonablative lasers treat a percentage of the skin surface while leaving surrounding tissue intact, allowing faster healing and less overall inflammation.

None of these protocols is risk-free. A 2022 systematic review in the Journal of the American Academy of Dermatology found that recurrence rates for melasma after laser treatment ranged from roughly 20 to 70 percent within one year, depending on sun exposure habits and hormonal factors. For a deeper clinical breakdown of how combination approaches are being used to reduce those recurrence numbers, ask a melasma-experienced clinician about current protocols.

Candidacy screening is where many adverse outcomes begin or are prevented. A thorough provider will use a Wood's lamp or dermoscopy to classify the melasma as epidermal, dermal, or mixed. Epidermal melasma responds better to laser. Dermal melasma, where pigment sits deeper in the dermis, is more resistant and carries a higher risk of PIH from aggressive energy delivery. Patients who are pregnant, taking oral contraceptives, or on photosensitizing medications are generally not good candidates until those variables are addressed. For related context, see our note on Laser for Spider Veins on the Legs: How It Works and What to Expect.

Recovery after a low-fluence laser toning session is typically minimal. Mild redness for a few hours, no significant peeling, and a return to normal activity the same day. Fractional nonablative treatments produce more visible recovery: two to five days of redness, mild swelling, and fine surface texture changes as treated columns of skin shed. Strict sun avoidance during recovery is not optional. Even brief unprotected sun exposure in the first two weeks after treatment can undo results and trigger the very rebound hyperpigmentation patients are trying to avoid.

Broad-spectrum SPF 50 sunscreen applied every two hours outdoors, physical sun protection like hats and UV-blocking windows, and in many cases a prescribed topical regimen combining hydroquinone, tretinoin, and a mild corticosteroid are used before and after laser to reduce baseline melanocyte activity. This combination approach, sometimes called triple combination therapy, is considered standard of care for melasma management, not a standalone laser protocol.

Cost varies considerably by market, device, and number of sessions required. In major metropolitan areas, a single laser toning session typically runs 300 to 600 dollars. Picosecond laser sessions tend to range from 400 to 900 dollars per treatment. Most providers recommend a series of four to six initial sessions, sometimes more, with maintenance treatments every two to three months. A realistic budget for a full course with maintenance over one year is often 2,000 to 6,000 dollars depending on location and protocol.

The honest answer to the original question: yes, laser can make melasma worse, and it does in a meaningful percentage of cases. The risk is highest with the wrong device for a given skin tone, excessive energy settings, inadequate pre-treatment preparation, and poor sun protection afterward. With appropriate device selection, conservative settings, proper candidacy screening, and a disciplined post-treatment routine, laser is a legitimate tool for melasma management. It is not a cure, and it should be approached as one component of long-term pigmentation control rather than a single definitive fix.

Related reading: Laser for Neck Wrinkles and Crepey Skin: A Clinical Treatment Guide, Laser vs Chemical Peel for Sun Damage: Mechanism, Recovery, and Results.